Injection Zeptide (Mounjaro Alternative in Pakistan) | The Cheapest Tirzepatide Available

Description

Injection Zeptide® — (Tirzepatide)

Ferozsons / BF Biosciences — Pakistan’s locally produced tirzepatide (a Mounjaro®-class medicine)
Positioning: The most affordable Zeptide brand available in Pakistan for blood-sugar control and clinically-supported weight reduction.

What is Zeptide (Tirzepatide)

Zeptide contains tirzepatide, a once-weekly injectable medication that combines glucose-dependent insulinotropic peptide (GIP) and GLP-1 receptor activity to lower blood sugar and produce clinically meaningful weight loss in many patients with type 2 diabetes or obesity. Zeptide has recently been launched in Pakistan by BF Biosciences / Ferozsons.

Available strengths & retail prices (Pakistan)

• 2.5 mg — ₨ 2,950

• 5 mg — ₨ 3,950

• 7.5 mg — ₨ 4,950

• 10 mg — ₨ 5,950.

• 12.5 mg — ₨ 6,250

• 15 mg — ₨ 6,500.

(Prices shown are typical retail list prices from Pakistani pharmacies/online pharmacies at the time of writing — actual retail prices may vary by pharmacy and over time; please confirm at point of purchase.)

How is Zeptide Administered (dose & titration)

• Route: Subcutaneous (under the skin) injection — prefilled syringe/pen for once-weekly use.

• Starting dose: 2.5 mg once weekly for 4 weeks (this starter dose is for initiation and is not intended to provide full glycemic control).

• Titration: After 4 weeks, increase to 5 mg once weekly. If additional control/benefit is needed and tolerated, doses may be increased in 2.5 mg increments every ≥4 weeks up to a maximum of 15 mg once weekly. Typical maintenance doses used clinically are 5 mg, 10 mg or 15 mg once weekly. These recommendations follow established tirzepatide prescribing guidance. FDA Access Data+1

Important: Dose adjustments, the pace of titration, and whether to continue or stop therapy should be decided by a treating physician based on efficacy and tolerability (especially gastrointestinal side effects). Medscape Reference

Zeptide Uses / Indications

• Primary: Treatment of type 2 diabetes mellitus (T2DM) to improve glycemic control when used with diet and exercise. FDA Access Data

• Weight loss / obesity: Tirzepatide has been shown to produce substantial weight loss in clinical trials; it is used for weight management under clinical supervision (local regulatory approvals may vary by indication and country). Zeptide is being introduced in Pakistan for diabetes and obesity management.

Common side effects

Most side effects are gastrointestinal and dose-related. Commonly reported adverse effects include:

• Nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, dyspepsia.

• Injection-site reactions (redness, swelling).

• Fatigue, headache, burping or reflux.

• When used with insulin or insulin secretagogues (e.g., sulfonylureas) there is an increased risk of hypoglycemia.

Serious but uncommon risks & warnings

• Thyroid C-cell tumor risk (rodent finding): Tirzepatide caused thyroid C-cell tumors in rodents. The human relevance is unknown; patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 should not use tirzepatide. This boxed warning appears in tirzepatide product labeling.

• Pancreatitis: There have been reports of acute pancreatitis with GLP-1 receptor agonists and tirzepatide; stop the drug promptly if pancreatitis is suspected.

• Acute kidney injury / dehydration: Severe gastrointestinal reactions (vomiting, diarrhea) can cause dehydration and may worsen kidney function.

• Hypersensitivity / allergic reactions and gallbladder-related events have been reported.

• Not for use in type 1 diabetes or for diabetic ketoacidosis.

Always read the full prescribing information and discuss risks with your doctor. FDA Access Data+1

Storage & practical notes

• Store refrigerated as instructed on the label (do not freeze). Protect from light and follow pharmacy instructions for cold-chain handling.

• Prefilled pens/syringes are for single-patient use. Do not share needles or pens.

• Keep out of reach of children.

Who should prescribe/supervise Zeptide Injections?

Zeptide is a prescription medication and must be started and monitored by a qualified healthcare provider (endocrinologist/diabetologist or GP experienced in diabetes care).

Baseline assessments (history of thyroid disease, pancreatitis risk factors, kidney function, and concomitant medicines that increase hypoglycemia risk) are recommended before starting.

For the Best Zeptide Injection Advice regarding Diabetes or Weight Loss, Consult Dr. Ahmed Farhan.

Legal/advisory disclaimer:

Disclaimer: This description is informational and not medical advice. Zeptide is a prescription drug — patients must consult a qualified healthcare professional before starting or changing therapy. Side effects and contraindications may occur; review the product insert and discuss risks/benefits with your prescriber. Prices listed are indicative retail prices and may change.